• AAA (Abdominal Aortic Aneurysm)
• Carotid Disease
• Limb Salvage
• Mesenteric Stenosis
• P.A.D (Peripheral Artery Disease- Stents, Angioplasty)
• Peripheral Aneurysms
• Spine Exposures
• T.A.A (Thoracic Aortic Aneurysm)
• Transcarotid Artery Revascularization (TCAR)
• Venous access (dialysis)
• Venous Disease – Blood clots, Venous Insufficiency, Varicose Veins

Fellowships

• University Of South Florida College Of Medicine, 2016, Vascular Surgery

Residency

• University Of Pennsylvania, 2014, Surgery

Internships

• University Of Pennsylvania, 2008, Surgery

Medical Education

• Universidad Central De Venezuela, Ciudad Universitaria, 2003

Certifications

• American Board of Surgery-Vascular Surgery

Publications

Peer-Reviewed Manuscripts 

• Redfield RR 3rd, Rodriguez E, Parsons R, Vivek K, Mustafa MM, Noorchashm H, Naji A. Essential role for B cells in transplantation tolerance. Curr Opin Immunol. 2011 Oct;23(5):685-91. 
• Vivek K, Mustafa MM, Rodriguez E, Redfield RR 3rd, Parsons RF, Rostami S, Migone TS, Cancro MP, Naji A, Noorchashm H. Strategies for B-lymphocyte repertoire remodeling in transplantation tolerance. Immunol Res. 2011 Oct;51(1):1-4.
• Redfield RR, Parsons RF, Rodriguez E, Mustafa M, Cassuto J, Vivek K, Noorchashm H, Naji A, Levine MH, Abt PL. Underutilization of A2 ABO incompatible kidney transplantation. Clin Transplant. 2012 May-Jun;26(3):489-94. 
• Parsons RF, Redfield RR 3rd, Rodriguez E, Mustafa MM, Vivek K, Murayama M, Naji A, Noorchashm H. Primary B cell repertoire remodeling to achieve humoral transplantation tolerance. Semin Immunol. 2012 Apr;24(2):109-14.
• Redfield RR, Lou Y, Rodriguez E, Rostami S, Parsons RF, Noorchashm H, Naji A, Abt PL. Sustained reduction of alloantibody secreting plasma cells and donor specific antibody with proteasome inhibition in mice. Transpl Immunol. 2013 Dec;29(1-4): 11-6.
• Redfield RR, Rodriguez E, Luo Y, Rostami S, Parsons RF, Noorchashm H, Abt PL, Naji A. Interleukin 5 immunotherapy depletes alloreactive plasma cells. J Surg Res. 2014 Mar;187(1):310-5
• Rodriguez E, Ouma G, Muthumani K, Weiner D, Wilensky RL, MD, Mohler III ER.
  In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia. J Vasc Surg. 2014 Mar;59(3):786-93.
• Redfield RR, Gupta M, Rodriguez E, Wood A, Abt PL, Levine MH. Graft and patient survival outcomes of a third kidney transplant. Transplantation. 2015 Feb;99(2):416-23.
• Dansey, K., Wooster, M., Powell, A., Rodriguez, E., Zwiebel, B., Shames, M. Rapid aneurysm growth after transarterial chemoembolization. Journal of Vascular Surgery Cases, Mar 2015; 1(1), 65-67

Professional Organizations

• Resident and Associate Society, American College of Surgeons
• Candidate Member, Society for Vascular Surgery
• Candidate Member, The Southern Association for Vascular Surgery

Presentations

• Noorchashm, Hooman, Rodriguez, Eduardo, Parsons, Ronald, Rostami, Susan Y., Reed, Amy J.,Cancro, Michael P., Naji, Ali. Humoral Tolerance to Murine Cardiac Allografts by Targeting the Critical Homeostatic Regulator of B-lymphocyte Selection, BLyS-BAFF. American Association of Thoracic Surgery annual meting. 2014.
• Rodriguez E, Rostami S, Mustafa M, Parsons R, Vivek K, Redfield R, Devalaraja S, Murayama M, Koeberlein B, Migone T, Cancro M, Naji A, Noorchashm H. BLyS Neutralization Abrogates Humoral Autoimmunity in a Chronic Heart Allograft Rejection Model. American Transplant Congress. 2012.
• Rodriguez E, Redfield R, Luo Y, Mustafa M, Rostami S, Devalaraja S, Murayama M, Parsons R, Abt P, Noorchashm H, Naji A. Anti-IL-5 Immunotherapy Depletes Alloreactive Plasma Cells. American Transplant Congress. 2012.
• Mustafa M, Vivek K, Ziaie A, Devalaraja S, Rostami S, Luo Y, Rodriguez E, Murayama M, Naji A. Inhibition of Autophagy Reduces Donor Specific Alloantibody in a Murine Skin-Allograft Model. American Transplant Congress. 2012.
• Rodriguez E, Redfield RR, Vivek K, Mustafa MM, Naji A, Noorchashm H. Dysregulated B Lymphocyte Tolerance to Self-Antigens Results from Cardiac Allograft Rejection. American Transplant Congress. 2011.
• Redfield RR, Parsons RF, Luo Y, Rostami S, Vivek K, Rodriguez E, Mustafa MM, Noorchashm H, Naji A, Abt PL. Bortezomib Alone Is Sufficient To Eliminate Plasma Cells and Donor-Specific Antibody in Mice. American Transplant Congress. 2011.
• Redfield RR, Luo Y, Rostami S, Vivek K, Rodriguez E, Mustafa MM, Noorchashm H, Naji A, Abt PL., Parsons RF, RANKL-Directed Immunotherapy Reduces Donor Specific Antibodies in Sensitized Mice. American Transplant Congress. 2011.
• Vivek K, Rostami S, Mustafa M, Rodriguez E, Redfield RR, Luo Y, Ziaie S, Parsons, RF, Migone TS, Cancro MP, Naji A, Noorchashm.H. B-Lymphocyte Directed Immunotherapy at the Time of Induction Is Insufficient for the Establishment of Humoral Transplantation Tolerance. American Transplant Congress. 2011.
• Vivek K, Rostami S, Mustafa M, Rodriguez E, Redfield RR, Luo Y, Ziaie S, Parsons, RF, Migone TS, Cancro MP, Naji A, Noorchashm.H. BLyS-Directed Immunotherapy Purges Alloreactive Specificities from the Primary B-Cell Repertoire and Promotes Humoral Transplantation Tolerance. American Transplant Congress. 2011.